Gold(III)-Dithiocarbamato Peptidomimetics in the Forefront of the Targeted Anticancer Therapy: Preclinical Studies against Human Breast NeoplasiaChiara Nardon, Q. Ping Dou|PLoS ONE|2014Cited by 48